Apprehension Builds as FDA Aims to Get its Quality Initiative Right the Second Time
This article was originally published in The Gold Sheet
Executive Summary
As FDA lays out plans to unleash the potential of new manufacturing technologies by reorganizing its quality oversight around metrics, industry worries about the risk of unintended consequences.